 |
 |
> Boehringer Ingelheim is conducting blind tests in Canada on a new drug > PRAMIPEXOLE. Results should be coming in shortly. Thanks for reminding me. There have been some positive accounts posted on this net re this drug (a dopamine agonist) by people here in the US who have been involved in testing it. I call the Upjohn Co. a couple of days ago to see what its status it (hoping I might be included in the testing), and here is what they told me: They concluded "phase 3" of their testing at the end of 1994. The drug looks promising in the treatment of early PD. They will be evaluating the studies and possibly be submitting a NDA (New Drug Application) by the end of 1995. From there, it goes to FDA for approval. The public relations person I spoke with estimated it would by 1997 (or late 1996) before this drug would be marketable here. ================================================================ Margaret Monty [log in to unmask] ================================================================